Zentalis Pharmaceuticals (NasdaqGM:ZNTL) FY Conference Transcript

Zentalis Pharmaceuticals (NasdaqGM:ZNTL) FY Conference September 08, 2025 02:30 PM ET Company ParticipantsJulie Eastland - CEO, President & DirectorCharles Wallace - Equity Research Associate - BiotechCharles Wallace207th Annual Global Investment Conference. My name is Charles Wallace, and I'm with the Equity Research Team. It's my pleasure to welcome Zentalis Pharmaceuticals, ticker ZNTL. Zentalis is a clinical-stage biopharmaceutical company, and their lead asset, azenosertib, or ZN-c3, is a potentially f ...